Thursday May 17th
 |
08:30 am 10:30 am |
•
•
•
• |
Academic Session I Metabolic syndrome and diabetes: risk factors Chair: Al-Rubeaan Khalid (Saudi Arabia) Metabolic syndrome: risk factors and pharmacotherapy Sadikot Shaukat M. (India) Diabetes type II and Alzheimer’s disease Biessels Geert Jan (The Netherlands) Metabolic syndrome and diabetes as risk factors for stroke Caso Valeria (Italy) Family history, ethics and chronic diseases in general Hamamy Hanan (Switzerland) |
10:30 am 11:00 am |
|
Coffee Break |
11:00 am 12:30 pm |
•
•
•
• |
Symposium sponsored by Kowa Management of HDL-C in patients with diabetes and metabolic syndrome Chair: Fruchart Jean-Charles (France) HDL in cardiometabolic disease: a therapeutic target? Chapman Martin John (France) Pitavastatin vs. other statins: improving therapeutic profile Masana Luis (Spain) Pitavastatin: new horizons for the management of dyslipidemia Kita Toru (Japan) Clinical effects of pitavastatin in patients with diabetes and metabolic syndrome Teramoto Tamio (Japan) |
12:30 pm 02:00 pm |
|
Lunch |
02:00 pm 04:00 pm |
•
•
•
• |
Academic Session II Diabetes management Chair: Sadikot Shaukat M. (India) Antihyperglycemic therapy and cardiovascular reduction Valensi Paul (France) Predicting and preventing diabetes and its complications: the role of biomarkers Koenig Wolfgang (Germany) Hypertriglyceridemia: therapeutic challenges Fruchart Jean-Charles (France) Prevention of the vascular complications of diabetes type II Hermans Michel (Belgium) |
04:00 pm 04:30 pm |
|
Coffee Break |
04:30 pm 05:30 pm |
•
• |
Fondation Cœur et Artères Symposium Adherence to cardiovascular therapies: can do better! Chair: Davignon Jean (Canada) Evidence-based pharmacotherapy after myocardial: adherence-associated factors and relationship with 30-month mortality and rehospitalization Tuppin Philippe (France) The general problem of adherence to long-term therapies in chronic diseases such as cardiometabolic disorders Duriez Patrick (France) |
